Table 3.

The effect of rHV3 eye drops on the activity of AR in the lens on diabetic cataract in Sprague-Dawley rats ($\overline{x}\pm s$).

Group	n	AR (mU/mg protein)
A	8	8.30 ± 0.48∗∗##
B	8	19.38 ± 1.37
C	8	17.88 ± 2.8
D	8	17.05 ± 1.98
E	8	14.17 ± 1.23**
F	8	16.53 ± 1.87*

 *P < 0.05, **P < 0.01 versus group B (model, treated with eye drops vehicle).

  ^# P < 0.05, ^## P < 0.01 versus group F (pirenoxine treated).